ArticleFrontiers in immunology2021

Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.

Po-Ku Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.